Reporte zur Charge 2N7NP4

Symptomtext

Third dose given; This case was reported by a pharmacist via call center representative and described the occurrence of extra dose administered in a 73-year-old male patient who received Herpes zoster (Shingrix) (batch number L5A35, expiry date 4th September 2023) and (batch number 2N7NP4, expiry date 4th September 2023) for prophylaxis. Previously administered products included Shingrix (2nd dose received on 23rd August 2018). On 14th December 2021, the patient received the 3rd dose of Shingrix. On 14th December 2021, the dose was an unknown dose. On 14th December 2021, unknown after receiving Shingrix, the patient experienced extra dose administered. On an unknown date, the outcome of the extra dose administered was unknown. Additional details were provided are as follows: The health care professional reported that, recently the patient was administered with 3rd dose of Shingrix, which led to extra dose administered. The reporter could not clarify which lot number was for powder and liquid (vial 1- L5A35 and vital 2- 2N7NP4). The reporter consented to follow-up.